In a nutshell, DN research has evolved from research focused on distinct dysregulated pathways, such as AGE, PKC, and AR, into an entirely novel discipline that focuses on insulin sensitivity and resistance, understanding global whole-nerve metabolism, nutrient overload, and the glial cells as an integral factor in DN. The gene discussed is PRRT2; the disease is liver dysplastic nodule.